PIK3CA and neoplasm: Patients with mutations in the PIK3CA gene were slightly younger than subjects without such mutations (median 62.5 years, range 39–85 vs. median 67 years, range 20–92; p = 0.045), while there were no statistically significant associations with gender, tumor location or advanced stage of the disease.